Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

NCT07649681 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT07649681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07649681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention
Lead sponsor
Wuerzburg University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 24, 2026
Completion date
December 31, 2026
Enrollment
198 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gi cancer, melanoma (skin cancer), multiple myeloma (mm), taste disorder, urogenital cancers